Postgraduate Master's Degree Program "Drug Regulatory Affairs"

The University of Bonn, in cooperation with the German Society for Regulatory Affairs (Deutsche Gesellschaft für Regulatory Affairs e.V.), offers the postgraduate Master's degree program "Drug Regulatory Affairs" (MDRA). The course is interdisciplinary, combining the fields of pharmacy, law and medicine, and includes specific, practice-oriented postgraduate training.

© Colourbox

What the study program offers

With the title "Master of Drug Regulatory Affairs" you will obtain an internationally recognised academic degree in a forward-looking field with excellent career prospects.

You will meet with representatives from authorities, pharmaceutical companies and the university, enabling you to build up a network for your professional future during your studies.
You will be provided with up-to-date knowledge from the various subject areas of regulatory affairs for effective and successful work. A wide range of topics from the life cycle of medicinal products and medical devices, quality and document management, reimbursement and regulatory-strategic planning will give you a comprehensive overview.
You can expect a dedicated team of over 100 lecturers made up of experts from the fields of pharmacy, toxicology, medicine and law.

As a postgraduate Master's degree program, the course offers further qualification for professional life and enables participants to understand, analyse and critically evaluate current topics and changes in the field of regulatory affairs on the basis of the skills they have learned.

Key Data of the Program

Nummer 4.jpg
© Bernadett Yehdou / Universität Bonn

Degree:                                    M.D.R.A. „Master of Drug Regulatory Affairs“

Credit points:                         120 ECTS

Type of study:                       Continuing education

Teaching concept:              Online and classroom teaching (50/50)

Language of instruction:   German and English

Duration of study:                 4 - 6 semesters of study

Start of program:                  Winter and summer semester

Tuition:                                      8.000 €

Course of Study 

© Uni Bonn

The program comprises twelve compulsory modules as well as a six-month internship and the Master's thesis.

1st semester 
Modules 1-6, written or oral examination in the last four weeks

2nd semester
Modules 7-12, written or oral examination in the last four weeks

3rd semester 
Internship (6 months full-time; part-time accordingly longer)

4th semester 
Master's thesis (6 months)

Admission requirements

The postgraduate Master's degree program "Drug Regulatory Affairs" is aimed at applicants who
1.    can prove a first relevant professionally qualifying university degree (at least 180 LP) and
2.    at least two years of relevant professional experience at the start of the program as well as
3.    language skills in German (C1) and English (B2).

Application procedure

If you have any questions about the application process, please contact
Eva-Maria Eibl and Dr. Jasmin Fahnenstich are available to answer your questions.

After Graduation: Possible professional fields

MDRA students and graduates work in various professional fields. They work in the pharmaceutical industry, in national and international authorities involved in approval procedures or drug monitoring and in higher federal authorities within the remit of the Federal Ministry of Health.
Other possible professional activities can be found in centers for clinical studies, contract research institutes and consulting companies. Law firms, ethics committees, professional associations and specialist societies also fall within the professional fields of regulatory affairs managers. Universities and research institutions also offer jobs in research and teaching.

For more information about the study program, please visit our website or contact us directly.

Contact Us

Avatar Fahnenstich, M.D.R.A.

Dr. Jasmin Fahnenstich, M.D.R.A.

Scientific Assistant MDRA
Avatar Eibl

Dipl.-Biol. Eva-Maria Eibl

Assistant MDRA

Our Cooperation Partner

Wird geladen